Ikarian Healthcare Master Fund, L.p. - Net Worth and Insider Trading

Ikarian Healthcare Master Fund, L.p. Net Worth

The estimated net worth of Ikarian Healthcare Master Fund, L.p. is at least $4,754 dollars as of 2024-11-11. Ikarian Healthcare Master Fund, L.p. is the of TRACON Pharmaceuticals Inc and owns about 135,842 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $4,754. Details can be seen in Ikarian Healthcare Master Fund, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ikarian Healthcare Master Fund, L.p. has not made any transactions after 2020-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ikarian Healthcare Master Fund, L.p.

To

Ikarian Healthcare Master Fund, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ikarian Healthcare Master Fund, L.p. owns 1 companies in total, including TRACON Pharmaceuticals Inc (TCON) .

Click here to see the complete history of Ikarian Healthcare Master Fund, L.p.’s form 4 insider trades.

Insider Ownership Summary of Ikarian Healthcare Master Fund, L.p.

Ticker Comapny Transaction Date Type of Owner
TCON TRACON Pharmaceuticals Inc 2020-12-30 10 percent owner & other: Member of 10% Group

Ikarian Healthcare Master Fund, L.p. Latest Holdings Summary

Ikarian Healthcare Master Fund, L.p. currently owns a total of 1 stock. Ikarian Healthcare Master Fund, L.p. owns 135,842 shares of TRACON Pharmaceuticals Inc (TCON) as of December 30, 2020, with a value of $4,754.

Latest Holdings of Ikarian Healthcare Master Fund, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCON TRACON Pharmaceuticals Inc 2020-12-30 135,842 0.04 4,754

Holding Weightings of Ikarian Healthcare Master Fund, L.p.


Ikarian Healthcare Master Fund, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Ikarian Healthcare Master Fund, L.p. has made a total of 4 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the acquisition of 26,015 shares on December 30, 2020, which cost Ikarian Healthcare Master Fund, L.p. around $5 Million.

Insider Trading History of Ikarian Healthcare Master Fund, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ikarian Healthcare Master Fund, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Ikarian Healthcare Master Fund, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ikarian Healthcare Master Fund, L.p. is 50.04%. GuruFocus also compares Ikarian Healthcare Master Fund, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Ikarian Healthcare Master Fund, L.p. within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ikarian Healthcare Master Fund, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ikarian Healthcare Master Fund, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.37 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.82 LIMIT LIMIT LIMIT LIMIT LIMIT

Ikarian Healthcare Master Fund, L.p. Ownership Network

Ownership Network List of Ikarian Healthcare Master Fund, L.p.

No Data

Ownership Network Relation of Ikarian Healthcare Master Fund, L.p.

Insider Network Chart

Ikarian Healthcare Master Fund, L.p. Owned Company Details

What does TRACON Pharmaceuticals Inc do?

Who are the key executives at TRACON Pharmaceuticals Inc?

Ikarian Healthcare Master Fund, L.p. is the 10 percent owner & other: Member of 10% Group of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .

TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary

Over the past 18 months, Ikarian Healthcare Master Fund, L.p. made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,200 shares.

TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TRACON Pharmaceuticals Inc Insider Transactions

No Available Data

Ikarian Healthcare Master Fund, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Ikarian Healthcare Master Fund, L.p.. You might contact Ikarian Healthcare Master Fund, L.p. via mailing address: 100 Crescent Court, Suite 1620, Dallas Tx 75201.